Drugs for Quadriplegia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 52)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Benzocaine |
Approved, Investigational |
Phase 4 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
2 |
|
Tannic acid |
Approved |
Phase 4 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
3 |
|
Midodrine |
Approved |
Phase 4 |
|
133163-28-7, 42794-76-3 |
4195 |
Synonyms:
(+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide
(+-)-2-Amino-N-(b-hydroxy-2,5-dimethoxyphenethyl)acetamide
(+-)-2-Amino-N-(β-hydroxy-2,5-dimethoxyphenethyl)acetamide
(±)-2-amino-N-(β-hydroxy-2,5-dimethoxyphenethyl)acetamide
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide
2-Amino-N-(2,5-dimethoxy-b-hydroxyphenethyl)acetamide
2-Amino-N-(2,5-dimethoxy-β-hydroxyphenethyl)acetamide
A-4020 LINZ
Amatine
Cahill may roberts brand OF midodrine monohydrochloride
Christiaens brand OF midodrine monohydrochloride
DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid
DL-N1-(b-Hydroxy-2,5-dimethoxyphenethyl)glycinamid
DL-N1-(Î’-hydroxy-2,5-dimethoxyphenethyl)glycinamid
|
Gutron
Midodrin
Midodrina
Midodrine
Midodrine HCL
Midodrine hydrochloride
Midodrine monohydrochloride
Midodrinum
Midon
Monohydrochloride, midodrine
Nycomed brand OF midodrine monohydrochloride
ProAmatine
Shire brand OF midodrine monohydrochloride
ST 1085
ST-1085
|
|
4 |
|
Melatonin |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
73-31-4 |
896 |
Synonyms:
[<sup>3</sup>H]-melatonin|[<sup>3</sup>H]MLT
{N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} acetamide
{N-[2-(5-methoxyindol-3-yl)ethyl]-} acetamide
3-(2-Acetamidoethyl)-5-methoxyindole
5-Methoxy-N-acetyltryptamine
BCI-049
Circadin
Circadin®|MLT
GENERAL NUTRIT
HEALTH AID
HEIDADOUPPI
ICENIA
J5.258B
LIFE EXT
MELAPURE
Melatol
Melatonin
Melatonin (synth.) standard-grade
Melatonin (synth.) ultra-pure
Melatonina
Melatonine
Mélatonine
Melovine
MLT
|
MT6
N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)-acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]-acetamide
N-Acetyl-5-methoxytryptamine
N-Acetyl-5-methoxy-tryptamine
N-Acetyl-5-methoxy-tryptamine melatonine
NATROL
NATURE'S BLEND
NATURES BOUNTY
NSC-113928
NSC-56423
QUALITY HEALTH
Regulin
S.GARD
TRAVELAG
VESPRO
VYTALONIN
|
|
5 |
|
Anesthetics |
|
Phase 4 |
|
|
|
6 |
|
Anesthetics, General |
|
Phase 4 |
|
|
|
7 |
|
Omega 3 Fatty Acid |
|
Phase 4 |
|
|
|
8 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
9 |
|
Adrenergic alpha-Agonists |
|
Phase 4 |
|
|
|
10 |
|
Adrenergic Agonists |
|
Phase 4 |
|
|
|
11 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
12 |
|
Vasoconstrictor Agents |
|
Phase 4 |
|
|
|
13 |
|
Sympathomimetics |
|
Phase 4 |
|
|
|
14 |
|
Nitric Oxide |
Approved |
Phase 2, Phase 3 |
|
10102-43-9 |
145068 |
Synonyms:
(.)NO
(NO)(.)
[NO]
EDRF
Endogenous nitrate vasodilator
Endothelium-derived nitric oxide
Endothelium-derived relaxing factor
HYDROXYAMINE
INOmax
INOmax®|nitric oxide|nitrogen monoxide
Mononitrogen monoxide
Monoxide, mononitrogen
Monoxide, nitrogen
Monoxido de nitrogeno
Monóxido de nitrógeno
Monoxyde d'azote
Nitrate vasodilator, endogenous
NITRIC OXIDE
Nitric oxide, endothelium derived
Nitric oxide, endothelium-derived
Nitrogen monooxide
|
Nitrogen monoxide
Nitrogen oxide
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl radical
Nitroxide radical
Nitroxyl
NO
NO(.)
OHM-11771
Oxide, nitric
Oxido de nitrogeno(II)
óxido de nitrógeno(II)
Oxido nitrico
óxido nítrico
Oxyde azotique
Oxyde nitrique
Stickstoff(II)-oxid
Stickstoffmonoxid
Vasodilator, endogenous nitrate
|
|
15 |
|
Arginine |
Approved, Investigational, Nutraceutical |
Phase 2, Phase 3 |
|
74-79-3 |
6322 |
Synonyms:
(2S)-2-Amino-5-(carbamimidamido)pentanoate
(2S)-2-Amino-5-(carbamimidamido)pentanoic acid
(2S)-2-AMINO-5-(DIAMINOMETHYLIDENEAMINO)PENTANOIC ACID
(2S)-2-AMINO-5-[(DIAMINOMETHYLIDENE)AMINO]PENTANOIC ACID
(2S)-2-Amino-5-guanidinopentanoate
(2S)-2-Amino-5-guanidinopentanoic acid
(2S)-2-AMINO-5-GUANIDINO-PENTANOIC ACID
(S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoate
(S)-2-Amino-5-[(aminoiminomethyl)amino]-pentanoate
(S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid
(S)-2-Amino-5-[(aminoiminomethyl)amino]-pentanoic acid
(S)-2-Amino-5-guanidinopentanoate
(S)-2-Amino-5-guanidinopentanoic acid
(S)-2-Amino-5-guanidinovalerate
(S)-2-Amino-5-guanidinovaleric acid
2-Amino-5-guanidinovalerate
2-Amino-5-guanidinovaleric acid
5-[(Aminoiminomethyl)amino]-L-norvaline
Arg
Arginina
Arginine
|
Arginine hydrochloride
Arginine, L isomer
Arginine, L-isomer
DL Arginine acetate, monohydrate
DL-Arginine acetate, monohydrate
Hydrochloride, arginine
L Arginine
L-(+)-Arginine
L-a-Amino-D-guanidinovalerate
L-a-Amino-D-guanidinovaleric acid
L-alpha-Amino-delta-guanidinovalerate
L-alpha-Amino-delta-guanidinovaleric acid
L-Arg
L-Arginin
L-ARGININE
L-Isomer arginine
Monohydrate DL-arginine acetate
N5-(Aminoiminomethyl)-L-ornithine
NSC-206269
R
|
|
16 |
|
NG-Nitroarginine Methyl Ester |
|
Phase 2, Phase 3 |
|
|
|
17 |
|
Buspirone |
Approved, Investigational |
Phase 1, Phase 2 |
|
36505-84-7 |
2477 |
Synonyms:
8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione
Anxut
Apo buspirone
Apo-buspirone
Apotex brand OF buspirone hydrochloride
Armstrong brand OF buspirone hydrochloride
BCI-024
Bespar
Bristol myers brand OF buspirone hydrochloride
Bristol myers squibb brand OF buspirone hydrochloride
Bristol-myers brand OF buspirone hydrochloride
Bristol-myers squibb brand OF buspirone hydrochloride
Busp
Buspar
Buspar®|MJ-9022-1
Buspiron
Buspirona
Buspirone
Buspirone hydrochloride
Buspironum
Eisai brand OF buspirone hydrochloride
Gen buspirone
Gen-buspirone
Genpharm brand OF buspirone
|
Hexal brand OF buspirone hydrochloride
Hormosan brand OF buspirone hydrochloride
Hydrochloride, buspirone
Lin buspirone
Lin-buspirone
Linson pharma brand OF buspirone hydrochloride
MJ-9022-1
N-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide
Neurosine
Novo buspirone
Novo-buspirone
Novopharm brand OF buspirone hydrochloride
Nu buspirone
Nu pharm brand OF buspirone hydrochloride
Nu-buspirone
Nu-pharm brand OF buspirone hydrochloride
Pharmascience brand OF buspirone hydrochloride
PMS Buspirone
PMS-Buspirone
Ratio buspirone
Ratio-buspirone
Ratiopharm brand OF buspirone hydrochloride
UPSA brand OF buspirone hydrochloride
|
|
18 |
|
Anti-Anxiety Agents |
|
Phase 1, Phase 2 |
|
|
|
19 |
|
Psychotropic Drugs |
|
Phase 1, Phase 2 |
|
|
|
20 |
|
Serotonin Receptor Agonists |
|
Phase 1, Phase 2 |
|
|
|
21 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 1, Phase 2 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
22 |
|
Tiotropium |
Approved |
Phase 1 |
|
136310-93-5, 186691-13-4 |
3086655 5487427 5487426 |
Synonyms:
679 BR, BA
7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide
BA 679 BR
BA679 BR
BA-679 BR
BA-679BR
BA-679-BR
BA-679-BR|Spiriva®
BR, BA 679
|
BRALTUS
Bromide, tiotropium
Spiriva
SPIRIVA RESPIMAT
TIOTROPIUM
Tiotropium bromide
TIOTROPIUM BROMIDE HYDRATE
TIOTROPIUM BROMIDE MONOHYDRATE
|
|
23 |
|
Chlorhexidine |
Approved, Vet_approved, Withdrawn |
Phase 1 |
|
55-56-1 |
2713 9552079 |
Synonyms:
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
AVAGARD
CHLORHEXIDIN
CHLORHEXIDIN [CZECH]
CHLORHEXIDINE
CHLORHEXIDINUM
CHLORHEXIDINUM [INN-LATIN]
Cloresidina
CLORESIDINA [DCIT]
CLORHEXIDINA
CLORHEXIDINA [INN-SPANISH]
|
Dentisept
EXIDINE
HIBISTAT
Merfen-incolore
N-(4-CHLOROPHENYL)-1-3-(6-{N-[3-(4-CHLOROPHENYL)CARBAMIMIDAMIDOMETHANIMIDOYL]AMINO}HEXYL)CARBAMIMIDAMIDOMETHANIMIDAMIDE
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NOLVASAN
PERIDEX
STERILON
SUTHOL
SUTHOOOL
|
|
24 |
|
Bronchodilator Agents |
|
Phase 1 |
|
|
|
25 |
|
Anti-Asthmatic Agents |
|
Phase 1 |
|
|
|
26 |
|
Respiratory System Agents |
|
Phase 1 |
|
|
|
27 |
|
Cholinergic Antagonists |
|
Phase 1 |
|
|
|
28 |
|
Cholinergic Agents |
|
Phase 1 |
|
|
|
29 |
|
Parasympatholytics |
|
Phase 1 |
|
|
|
30 |
|
Bromides |
|
Phase 1 |
|
|
|
31 |
|
Adrenergic beta-Agonists |
|
Phase 1 |
|
|
|
32 |
|
Salmeterol Xinafoate |
|
Phase 1 |
|
94749-08-3 |
|
Synonyms:
GR-33343 G
GR-33343-G
GR-33343X
LIPO-202
|
SALMETEROL 1-HYDROXY-2-NAPHTHOATE
SALMETEROL XINAFOATE
SEREVENT
|
|
33 |
|
Chlorhexidine gluconate |
|
Phase 1 |
|
|
|
34 |
|
Antioxidants |
|
Phase 1 |
|
|
|
35 |
|
Hemostatics |
|
Phase 1 |
|
|
|
36 |
|
Protective Agents |
|
Phase 1 |
|
|
|
37 |
|
Papaya |
Approved |
|
|
|
|
38 |
|
Mometasone furoate |
Approved, Investigational, Vet_approved |
|
|
83919-23-7 |
4240 441336 |
Synonyms:
(9BETA,10ALPHA,11ALPHA,14BETA,16ALPHA,17ALPHA)-9,21-DICHLORO-11-HYDROXY-16-METHYL-3,20-DIOXOPREGNA-1,4-DIEN-17-YL FURAN-2-CARBOXYLATE
ASMANEX
ASMANEX HFA
ASMANEX TWISTHALER
ELOCON
MOMETASONE
MOMETASONE 17-FUROATE
|
MOMETASONE FUROATE
Mometasone furoate anhydrous
MOMETASONE FUROATE MONOHYDRATE
Mometasone furoic acid
NASONEX
SCH-32088
SINUVA
|
|
39 |
|
Ipratropium |
Approved, Experimental |
|
|
22254-24-6, 60205-81-4 |
657309 3746 |
Synonyms:
(endo,Syn)-(+-)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane
(endo,Syn)-(+-)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide
3a-Hydroxy-8-isopropyl-1alphah,5alphah-tropanium bromide (+-)-tropate
3a-Hydroxy-8-isopropyl-1alphah,5alphah-tropanium bromide (+-)-tropic acid
3alpha-Hydroxy-8-isopropyl-1alphah,5alphah-tropanium bromide (+-)-tropate
3alpha-Hydroxy-8-isopropyl-1alphah,5alphah-tropanium bromide (+-)-tropic acid
3Α-hydroxy-8-isopropyl-1alphah,5alphah-tropanium bromide (+-)-tropate
3Α-hydroxy-8-isopropyl-1alphah,5alphah-tropanium bromide (+-)-tropic acid
8-Isopropylnoratropine methobromide
Anhydrous, ipratropium bromide
Atrovent
ATROVENT AEROCAPS
ATROVENT FTE
ATROVENT HFA
ATROVENT UDVS
Atrovent®|Ipraxa®
Bromide anhydrous, ipratropium
Bromide monohydrate, ipratropium
Bromure d'ipratropium
Bromuro de ipratropio
Ipatropium bromide
IPRATROP
IPRATROP STERIPOULE
Ipratropii bromidum
|
Ipratropium
Ipratropium bromide
Ipratropium bromide (anhydrous)
Ipratropium bromide anhydrous
IPRATROPIUM BROMIDE HYDRATE
Ipratropium bromide monohydrate
Ipratropium bromide, (endo,anti)-isomer
Ipratropium bromide, (exo,syn)-isomer
Ipratropium bromide, endo-isomer
Ipratropium cation
Ipratropium ion
Ipratropiumbromid
Itrop
Monohydrate, ipratropium bromide
N Isopropylatropine
N-Isopropylatropine
N-Isopropylnoratropinium bromomethylate
N-Isopropylnoratropinium bromomethylic acid
RESPONTIN
RINATEC
SCH-1000-BR-
SCH-1000-BR MONOHYDRATE
TROPIOVENT
|
|
40 |
|
Enalaprilat |
Approved |
|
|
76420-72-9 |
6917719 5462501 |
Synonyms:
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
Anhydrous enalaprilat citrate
Anhydrous, enalaprilat
Biovail brand OF enalaprilat anhydrous
Boehringer ingelheim brand OF enalaprilat anhydrous
Dihydrate, enalaprilat
Enalapril acid
Enalapril diacid
Enalapril teva
ENALAPRILAT
Enalaprilat anhydrous
Enalaprilat citrate, anhydrous
Enalaprilat dihydrate
Enalaprilat, (R)-isomer, anhydrous
|
Enalaprilate
Enalaprilatum
Enalaprilic acid
Enalapril-teva
EnalaprilTEVA
Merck frosst brand OF enalaprilat anhydrous
MK-421
MK-422
MSD Brand OF enalaprilat
N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl-L-proline
Pres IV
Teva brand OF enalaprilat
Vasotec
Xanef
|
|
41 |
|
Enalapril |
Approved, Vet_approved |
|
|
75847-73-3 |
40466924 5388962 5362032 |
Synonyms:
(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline
(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylate
(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester
Analapril
ánalapril
Bonuten
C09AA02
ENALADEX
Enaladex®|Vasotec®
Enalapril
Enalapril Bp
Enalapril maleate
Enalapril Richet
Enalaprila
|
Enalaprila [INN-Spanish]
Enalaprilat
Enalaprilum
Enalaprilum [INN-Latin]
EPL753
Gadopril
Kinfil
LEXXEL
Maleate, enalapril
Renitec
Renitek
VASERETIC
VASOTEC
Vasotec IV
|
|
42 |
|
Silicon |
Approved, Investigational |
|
|
7440-21-3 |
4082203 |
Synonyms:
|
Silicate
Silicic acid
silicio
|
|
43 |
|
Metronidazole |
Approved |
|
|
443-48-1, 69198-10-3 |
4173 |
Synonyms:
1-(2-Hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(b-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(b-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(b-Oxyethyl)-2-methyl-5-nitroimidazole
1-(Î’-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(Î’-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(Î’-oxyethyl)-2-methyl-5-nitroimidazole
2 Methyl 5 nitroimidazole 1 ethanol
2-Methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-Methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-Methyl-5-nitroimidazole-1-ethanol
ACEA
Acromona
ANABACT
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAY-5360
Bayer 5360
BAYER-5360
Bexon
Clont
Cont
Danizol
Deflamon
Deflamon-Wirkstoff
DRAZIFON
Efloran
ELYZOL
Entizol
Eumin
Flagemona
Flagesol
Flagil
Flagyl
FLAGYL 375
FLAGYL COMPAK
FLAGYL ER
Flagyl I.V.
FLAGYL I.V. RTU IN PLASTIC CONTAINER
FLAGYL-400
FLAGYL-S
Flegyl
Fossyol
Giatricol
Gineflavir
Hydrochloride, metronidazole
Klion
Klont
Meronidal
Methronidazole
Metric
METRIC 21
Metro Cream
Metro I.V.
Metro I.V. In Plastic Container
METRO IV
METROCREAM
Metrodzhil
MetroGel
Metrogel-vaginal
Metrogyl
Metrolag
METROLOTION
METROLYL
|
METROMIDOL
Metronidaz
Metronidazol
METRONIDAZOLE
Métronidazole
Metronidazole benzoate
Metronidazole Hcl
Metronidazole hydrochloride
Metronidazole in plastic container
Metronidazole monohydrochloride
Metronidazole phosphate
Metronidazole phosphoester
Metronidazolo
Metronidazolum
METROSA
METROTOP
Mexibol
Monagyl
Monasin
Monohydrochloride, metronidazole
Nalox
Neo-Tric
NEUTRATOP
Nida
Nidagel
Noritate
Noritic acid
NORZOL
Novonidazol
NSC-50364
NSC-69587
NUVESSA
Orvagil
Phosphate, metronidazole
Phosphoester, metronidazole
PROTOSTAT
Rathimed
ROSICED
ROZEX
RP-8823
Sanatrichom
Satric
Takimetol
Trichazol
Trichex
Tricho Cordes
Trichocide
Tricho-Gynaedron
Trichomol
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
Vagilen
Vagimid
VAGINYL
VANDAZOLE
Vertisal
Wagitran
ZADSTAT
ZIDOVAL
ZYOMET
|
|
44 |
|
Insulin, Globin Zinc |
|
|
|
|
|
45 |
|
Insulin |
|
|
|
|
|
Synonyms:
AFREZZA
EXUBERA
HUMULIN
HUMULIN BR
HUMULIN R
HUMULIN R KWIKPEN
HUMULIN R PEN
INS HUMULIN R
INSULIN
INSULIN (HUMAN)
INSULIN BOVINE
INSULIN BOVINE INSULIN
|
INSULIN HUMAN
INSULIN HUMAN (BIOSYNTHESIS)
INSULIN HUMAN (SYNTHESIS)
INSULIN RECOMBINANT HUMAN
INSULIN RECOMBINANT PURIFIED HUMAN
INSUMAN INFUSAT
MYXREDLIN
NOVOLIN
NOVOLIN R
VELOSULIN
VELOSULIN BR
VELOSULIN BR HUMAN
|
|
46 |
|
Vitamins |
|
|
|
|
|
47 |
|
Whey Protein |
|
|
|
|
|
48 |
|
Antihypertensive Agents |
|
|
|
|
|
49 |
|
Angiotensin-Converting Enzyme Inhibitors |
|
|
|
|
|
50 |
|
HIV Protease Inhibitors |
|
|
|
|
|
Interventional clinical trials:
(show top 50)
(show all 130)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Early Nerve Reconstruction Approach in Tetraplegic Patients With Dysfunctional Upper Extremity: a Randomized Controlled Trial. |
Unknown status |
NCT01579604 |
Phase 4 |
|
2 |
A Longitudinal Clinical Feasibility Study to Evaluate the Psychological and Functional Effects of Using the Tobiiâ„¢ Eyegaze System by Inpatients With Tetraplegia |
Unknown status |
NCT01943656 |
Phase 4 |
|
3 |
Omega-3 Supplementation to Increase HDL-c Levels in Those With Tetraplegia |
Completed |
NCT01896037 |
Phase 4 |
|
4 |
Melatonin Replacement for Treatment of Sleep Disruption |
Completed |
NCT00507546 |
Phase 4 |
Ramelteon;Placebo |
5 |
Core Temperature During Cold Exposure in Persons With Tetraplegia |
Completed |
NCT01822535 |
Phase 4 |
Midodrine hydrochloride |
6 |
Phrenic Reinnervation in Central Ventilatory Paralysis Due to Medullary Trauma With Phrenic Motoneuron Destruction |
Completed |
NCT01350297 |
Phase 4 |
|
7 |
Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia |
Active, not recruiting |
NCT02379156 |
Phase 4 |
Midodrine Hydrochloride |
8 |
Activity-Dependent Plasticity After Spinal Cord Injury |
Unknown status |
NCT00059553 |
Phase 2, Phase 3 |
|
9 |
Evaluation of the Efficacy of "MEOPA" Used to Obtain Better ROM Immediately After Multilevel Surgery in Children With Spastic Diplegia, Quadriplegia or Hemiplegia. |
Completed |
NCT00632528 |
Phase 3 |
MEOPA;Medicinal air |
10 |
Outcome Evaluation of Exercise and Electrical Therapy for Quadriplegic Hand Function |
Completed |
NCT00656149 |
Phase 2, Phase 3 |
|
11 |
The Effect of Nitric Oxide on Pulmonary Resistances and Blood Pressure in Persons With Tetraplegia |
Completed |
NCT00753948 |
Phase 2, Phase 3 |
N-Nitro L-arginine-methylester (L-NAME) |
12 |
Prevention of Low Blood Pressure in Persons With Tetraplegia |
Completed |
NCT00237770 |
Phase 2, Phase 3 |
N-Nitro L-arginine-methylester (L-NAME) |
13 |
Improving Hand Function in Chronic SCI With Combined Robotic Training and tDCS |
Active, not recruiting |
NCT03555838 |
Phase 3 |
|
14 |
Randomised Open Study of the Efficiency and Tolerance of the Use of a Corset on the Respiratory Function of Spinal Cord Injury Patients |
Withdrawn |
NCT01569360 |
Phase 3 |
|
15 |
ASIA Motor, Functional and Health Related Quality of Life Outcome in Traumatic Central Cord Syndrome, a Prospective Randomized Study |
Unknown status |
NCT00475748 |
Phase 2 |
|
16 |
Safety and Efficacy of L-NAME and Midodrine to Increase MAP in Persons With Tetraplegia |
Completed |
NCT00835224 |
Phase 2 |
L-NAME;Midodrine;Placebo |
17 |
Rehabilitation and Cortical Remodeling After Surgical Intervention for Spinal Cord Injury |
Recruiting |
NCT04041063 |
Phase 2 |
|
18 |
Enabling Forelimb Function With Agonist Drug and Epidural Stimulation in SCI |
Active, not recruiting |
NCT02313194 |
Phase 1, Phase 2 |
Buspirone |
19 |
Rehabilitation of the Lower Extremity With AMES Following Incomplete Spinal Cord Injury (SCI) |
Terminated |
NCT01498991 |
Phase 1, Phase 2 |
|
20 |
Effect of Two Different Air-stacking Techniques, Combined With Manually Assisted Cough, on Peak Cough Flow (PCF) in Patients With Acute Cervical or High Thoracic Spinal Cord Injury |
Withdrawn |
NCT01046175 |
Phase 2 |
|
21 |
Improving Ambulatory Community Access After Paralysis |
Unknown status |
NCT01570816 |
Phase 1 |
|
22 |
Acute and Chronic Effects of an Anticholinergic Agent or a Long-Acting Beta 2 Agonist on Levels of Exhaled Nitric Oxide and Pulmonary Function in Persons With Tetraplegia |
Unknown status |
NCT01355991 |
Phase 1 |
Tiotropium;Salmeterol |
23 |
The Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Chronic Spinal Cord Injury (SCI) Receiving Rehabilitation |
Completed |
NCT02354625 |
Phase 1 |
|
24 |
Development and Translational Assessment of a Tongue-Based Assistive Neuro-Technology for Individuals With Severe Neurological Disorders |
Completed |
NCT01124292 |
Phase 1 |
|
25 |
The Role of Melatonin in the Regulation of Blood Coagulation |
Completed |
NCT01741389 |
Phase 1 |
Melatonin ("Circadin") |
26 |
Use of Interactive Gaming After Spinal Cord Injury |
Completed |
NCT01537978 |
Phase 1 |
|
27 |
Clinical Evaluation of Brain-Computer Interface for Helping Communication of Quadriplegic Patients |
Unknown status |
NCT01707498 |
|
|
28 |
Development of a Spinal Cord Injury-specific Exercise-based Capacity |
Unknown status |
NCT02602639 |
|
|
29 |
Brain Computer Interface Based Communication in the Completely Locked-In State |
Unknown status |
NCT02980380 |
|
|
30 |
Developing Strategies to Optimize the Exercise Response in Persons Living With Tetraplegia. |
Unknown status |
NCT04465825 |
|
|
31 |
Body Composition Assessment in Spinal Cord Injury |
Unknown status |
NCT00957762 |
|
|
32 |
Abdominal Functional Electrical Stimulation to Augment Breathing in Tetraplegia |
Unknown status |
NCT00202631 |
|
|
33 |
A Randomized, Crossover Clinical Trial of Exoskeletal-assisted Walking to Improve Mobility, Bowel Function and Cardio-Metabolic Profiles in Persons With SCI |
Unknown status |
NCT02314221 |
|
|
34 |
Functional Electrical Stimulation Cycling in Acute Spinal Cord Injury; a Feasibility Study |
Unknown status |
NCT04064385 |
|
|
35 |
A Clinical Observational Follow-up Study of European Pediatric Cases of Acute Flaccid Myelitis Associated With EV-D68 Infection. |
Unknown status |
NCT03499366 |
|
|
36 |
A Feasibility Study of the Ability of the Neural Prosthetic System to Provide Direct Brain Control of Extracorporeal Devices in Patients With Quadriplegia Due to High Spinal Cord Injury |
Completed |
NCT01849822 |
|
|
37 |
Reanimation in Tetraplegia: Restoring Cortical Control of Functional Movement in Humans With Quadriplegia |
Completed |
NCT01997125 |
|
|
38 |
Finding the Optimal Voluntary Exercise Parameters for Generating a Health Benefit in Those Living With Quadriplegia |
Completed |
NCT03146728 |
|
|
39 |
Intermittent Theta Burst Stimulation to Promote Motor Re-education After Upper Limb Reconstruction in Tetraplegia |
Completed |
NCT03277521 |
|
|
40 |
Cardiovascular Parameters for Lokomat Training in Chronic Incomplete SCI |
Completed |
NCT00385918 |
|
|
41 |
Study of the Surgical Treatment of Cervical Spinal Cord Injuries With Nerve Transfers to Restore Upper Extremity and Hand Function |
Completed |
NCT01899664 |
|
|
42 |
Functional Evaluation of the Recovery of Prehension in Quadriplegics by Implanted Neural Stimulation |
Completed |
NCT04306328 |
|
|
43 |
Effectiveness of Standing Frame on Constipation in Children With Cerebral Palsy: a Single Subject Study |
Completed |
NCT01911559 |
|
|
44 |
Exercise to Reduce Obesity in Spinal Cord Injury |
Completed |
NCT00270855 |
|
|
45 |
Prospective Comparative Multicenter Study on the Medico-economical Impact of the Brindley Technique in the Management of Neurogenic Bladder in Patients With Injured Spinal Cord |
Completed |
NCT00221767 |
|
|
46 |
Multi-Center Pivotal Study of NeuRx RA/4 Ventilatory Assist Device |
Completed |
NCT00010374 |
|
|
47 |
Feasibility Study of the mindBEAGLE Device in Patients With Disorders of Consciousness or Locked-In Syndrome |
Completed |
NCT02772302 |
|
|
48 |
Electrical Stimulation in Denervated Muscles of the Upper Limbs - Effect on Muscle Morphological Properties - A Pilot Study |
Completed |
NCT03698136 |
|
|
49 |
Random Noise Stimulation to Enhance Corticomotor Drive for Improved Hand Function |
Completed |
NCT04777149 |
|
|
50 |
Conditioning Neural Circuits to Improve Upper Extremity Function |
Completed |
NCT02611375 |
|
|
Cochrane evidence based reviews: quadriplegia
|